Open AccessComparative In Vitro Activities of Retapamulin (SB-275833) against 141 Clinical Isolates of Propionibacterium spp., Including 117 P. acnes Isolates
Antimicrobial Agents And ChemotherapyPeer ReviewedEllie J. C. Goldstein +52005Journals
Using the NCCLS agar dilution method, we studied the in vitro activity of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium species, including seven multiresistant strains, and found retapamulin to be the most active agent among those tested with MICs of < or = 1 microg/ml against all isolates.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support